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p27kip1 (p27) is an inhibitor of cyclin/cyclin-dependent kinase complexes, whose nuclear loss indicates a poor
prognosis in various solid tumors. When located in the cytoplasm, p27 binds Op18/stathmin (stathmin), a
microtubule (MT)-destabilizing protein, and restrains its activity. This leads to MT stabilization, which
negatively affects cell migration. Here, we demonstrate that this p27 function also influences morphology and
motility of cells immersed in three-dimensional (3D)matrices. Cells lacking p27 display a decrease in MT
stability, a rounded shape when immersed in 3D environments, and a mesenchymal-amoeboid conversion in
their motility mode. Upon cell contact to extracellular matrix, the decreased MT stability observed in p27 null
cells results in accelerated lipid raft trafficking and increased RhoA activity. Importantly, cell morphology,
motility, MT network composition, and distribution of p27 null cells were rescued by the concomitant genetic
ablation of Stathmin, implicating that the balanced expression of p27 and stathmin represents a crucial
determinant for cytoskeletal organization and cellular behavior in 3D contexts.
The importance of developing and utilizing three-dimen-
sional (3D) models to understand the molecular and cellular
signaling events underlying in vivo biology is becoming increas-
ingly clear and critical, especially in cancer (50). To spread into
surrounding tissues and metastasize, tumor cells need to in-
crease their invasive potential, rearrange their cytoskeleton,
and remodel the extracellular matrix (ECM) (39). It has been
proposed that internal cytoskeletal dynamics and cellular mor-
phology can influence the environment recognition and subse-
quent choice of motility mode through the ECM, where cells
with elongated protrusions preferably move using a mesenchy-
mal motility while more rounded cells rather invade using an
amoeboid-like motility program (17). Mesenchymal migration
employs more stringent, focalized cell-matrix interactions and
Rac-driven protrusions and causes proteolytic ECM remodel-
ing, whereas amoeboid cell movement lacks focalized cell-
ECM interactions and is Rho/ROCK dependent, and cells
progress by squeezing their body rather than by ECM degra-
dation (38). Because they depend upon 3D interactions with
the surrounding tissue, these processes can hardly be investi-
gated in standard 2D culture conditions, where intracellular
signaling pathways directing cell polarity, proliferation, and
differentiation are orchestrated in profoundly different ways
(17). Over the last few years, many proteins have been impli-
cated in the control of 2D versus 3D motility. Among others,
RhoA and its ubiquitin ligase Smurf1 have been demonstrated
to act in distinct ways whether cell motility is explored by 2D
tissue culture assay or by 3D and in vivo models, and their roles
during the migration process may greatly differ depending on
the cellular state and context (37, 38, 45).
p27kip1 (hereafter p27) is a cell cycle inhibitor that has been
implicated in the regulation of cell motility (2, 4, 6). We pre-
viously demonstrated that in early steps of cell adhesion to
ECM or when cells are immersed in 3D matrices, p27 trans-
locates to the cytoplasm, where it binds and inhibits stathmin,
a microtubule (MT)-destabilizing protein (2). In the absence of
p27, including when it has been knocked down or degraded in
tumors, a decrease in MT stability is then responsible for
increased motility and invasive potential of cells (2). On the
other hand, other reports have shown that absence of p27
impairs motility of cells when tested in 2D assays, such as
wound healing or random motility (6), thus suggesting that the
roles of p27 may be different, depending on cellular contexts.
It is well known that MTs are necessary for directional mo-
tility and provide a polarized network to allow organelle and
protein movements throughout the cell (47). This trafficking is
essential for receptor and integrin recycling, which, in turn, is
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required for migration (43). Rho GTPases, key regulators of
cell migration, also affect the microtubule cytoskeleton during
directed migration, contributing to its stabilization at the lead-
ing edge (at least in part through stathmin inhibition) and
to the repositioning of the microtubule organizing center
(MTOC) (14, 36). In turn, MTs can modulate Rho GTPase
activity, with MT outgrowth activating Rac1 and MT disrup-
tion activating RhoA, although the molecular mechanism of
these regulations under physiological and pathological condi-
tions is not completely understood (11, 43, 47).
Interestingly, Rho GTPase activity has been shown to be
negatively regulated by p27 during 2D migration (6), thus
suggesting that cross talk among these different molecules and
signaling pathways must exist to appropriately coordinate and
fulfill complex cellular functions, such as migration, invasion,
and division.
Here, we demonstrate that p27 regulates lipid raft trafficking
and Rho GTPase activity via its interaction with stathmin and
that this molecular pathway is probably involved in the control
of cell morphology and motility in 3D environments.
MATERIALS AND METHODS
Cell culture, retroviral transduction, and PCR on genomic DNA. 3T3 fibro-
blasts and mouse embryonic fibroblasts (MEFs) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS; Sigma). Primary wild-type (WT), p27 knockout (KO), and p27/stathmin
DKO MEFs were prepared from embryos at day 13.5, according to standard
procedures. Primary MEFs (at least five different preparations/genotype) were
used between passages 3 and 5 without significant differences. The correct ge-
notype of WT, p27 KO, and p27/stathmin DKO cells, was determined by PCR,
as described previously (2, 16). 3T3 fibroblasts were obtained from primary
MEFs following the 3T3 immortalization protocol. Cell clones of 3T3 p27 WT or
KO stably expressing stathmin and 3T3 p27 KO stably expressing p27 or the
empty vectors were obtained by retroviral transduction with a vector carrying
puromycin resistance (murine stem cell virus retroviral vectors; Clontech), fol-
lowing the manufacturer’s instructions. 293T/17 cells (ATCC CRL-11268) used
to produce retroviruses were grown in DMEM supplemented with 10% FBS
(Sigma).
Caveolin 1-silenced p27 KO cells were generated using two different shRNAs
against mouse caveolin 1 from the MISSION library (TRCN0000112662 and
TRCN0000112664; SigmaAldrich) (32), using either transient or stable (puro-
mycin-selected) lentiviral transduction, with no significant differences (data not
shown, but see Fig. 6, below). In the same cells, the nontarget sh-control vector
(SHC202; SigmaAldrich) has been used as control.
Proliferation assays. Proliferation was assessed by 3-(4,5-dimethyl-2-thia-
zolyl)-2,5-diphenyl-2H-tetrazolium bromide assay (Sigma) or by fluorescence-
activated cell sorting analysis, as described in references 2 and 3.
Adhesion and migration assays. For adhesion experiments, cells were starved
overnight in DMEM–0.1% FBS and then detached and seeded onto dishes
coated with fibronectin (FN; 10 g/ml; Sigma). Where indicated, paclitaxel
(Taxol; 100 nM; TEVA), C3-exoenzyme (2 ng/ml; Cytoskeleton), and Y27632
(10 M; Calbiochem) were added during adhesion. To differentially extract
soluble and polymerized protein fractions, at indicated times cells were scraped
at room temperature in MT-stabilizing buffer [MSB; 85 mM piperazine-N,N-
bis(2-ethanesulfonic acid) (PIPES; pH 6.5), 1 mM EGTA, 1 mM MgCl2, 2 M
glycerol, 0.5% Triton X-100, 4 g/ml paclitaxel, and protease inhibitors) or at
4°C in NP-40 lysis buffer for total lysates (2). Haptotaxis was performed by
labeling cells with DiI fluorescent vital dye (Molecular Probes) and plating 1 
105 cells in the upper chamber of transwell-like inserts, carrying a fluorescence-
shielding porous polyethylene terephthalate membrane with 0.8-m pores (HTS
FluoroBlok; BD) previously coated on the underside with FN (20 g/ml) or
collagen I (20 g/ml; BD), as indicated. The time-dependent migratory behavior
of the cells was monitored by using a SPECTRAFluor Plus microplate fluoro-
meter, as described previously (2). The quantitative cell adhesion assay (centrif-
ugal assay for fluorescence-based cell adhesion [CAFCA]) used in this study has
been previously described (2).
Time-lapse microscopy. Time-lapse microscopy and cell tracking analyses
were performed as previously described (49). Briefly, cells were detached and
suspended in a buffered collagen I solution, pH 7.4, at 1.67 mg/ml final concen-
tration (Vitrogen). The suspension was allowed to polymerize for 30 min at 37°C
in a 5% CO2 atmosphere in a self-constructed 3D chamber and then overlaid
with serum-free medium (SFM). Pictures/images were collected every 4 min for
18 h using a charge-coupled-device camera mounted onto the microscope. Col-
lected images were used to create a movie (10 images per second) and analyzed
with a custom cell-tracking software to collect different locomotion parameters
(26). In brief, 40 cells were randomly selected and their x-y coordinates were
obtained for each step (12-min step interval), and the total distance and the
steady state as well as average cell speed were obtained for each cell of the
population.
Morphology in 3D and evasion assay. For the evaluation of cellular morphol-
ogy in 3D matrices, cells were included in Matrigel (6 mg/ml; BD) or collagen I
(1.7 mg/ml; BD or Vitrogen) 10-l drops on a coverslip (7.5  105 cells/ml) and
maintained for 1 h upside down at 37°C, to allow collagen I polymerization.
Then, complete medium or serum-free medium was added, as indicated. Drops
were incubated for the indicated times (6 to 8 h) and photographed using a
phase-contrast microscope to evaluate cell morphology. When indicated, cyto-
chalasin D (0.5 M; Sigma), nocodazole (1 M; Sigma), C3-exoenzyme (2 ng/ml;
Cytoskeleton), or Y27632 (10 M; Calbiochem) was added to the Matrigel or
collagen mix to include the cells and to the medium. In some cases, the shapes
of single cells immersed in 3D matrices were calculated by sorting them as round
(no dominant pseudopod), elongated (one to two protrusions), or stellate (more
than two protrusions). Evasion assays were set up in the same way, except that
cell drops were plated on plastic multiwell plates and evasion ability was esti-
mated 4 days after inclusion. Cells outside each drop (5 drops/cell line/experi-
ment) were counted to estimate the evasion ability of each cell line. The evasion
ability was also estimated by measuring the distance covered by crystal violet-
stained cells 10 days after inclusion.
Immunofluorescence analysis. For immunofluorescence staining, cells were
immersed in Matrigel or collagen I drops on coverslips for the indicated times
and fixed in phosphate-buffered saline (PBS)–4% paraformaldehyde (PFA) at
room temperature (RT), permeabilized in PBS–0.2% Triton X-100, and blocked
in PBS–1% bovine serum albumin (BSA) or 10% normal goat serum. Incubation
with primary antibodies (anti--tubulin–fluorescein isothiocyanate [FITC] and
anti-acetylated tubulin [Sigma]; pS3-cofilin [Cell Signaling]; RhoA [Upstate])
was performed overnight at 4°C in PBS–1% BSA or 1% normal goat serum, and
then samples were washed in PBS and incubated with secondary antibodies
(Alexa Fluor 488-, 546-, or 633-conjugated anti-mouse or anti-rabbit antibodies;
Invitrogen) for 1 h at RT. In some cases antibody incubation was followed by
staining of F-actin with phalloidin-tetramethyl rhodamine isocyanate or Alexa
Fluor 647 or Alexa Fluor 546 (Invitrogen) for 30 min at RT, by nuclear staining
with 1 g/ml Hoechst 33258 in PBS for 10 min at RT, or with 1 M Sytox Green
(Invitrogen) for 30 min at RT. Stained cells were then observed using a confocal
laser-scanning microscope (TSP2 Leica) interfaced with a Leica DMIRE2 fluo-
rescence microscope. Images were acquired using a Nikon Diaphot 200 epifluo-
rescence microscope equipped with distinguishing filters.
Tubulin dilution assay. The tubulin dilution assay was performed essentially as
described previously (2), with some modifications due to the inclusion of the cells
in 3D matrices. Briefly, cells included in 3D collagen I for 4 h were incubated in
PEM buffer (80 mM PIPES, 1 mM MgCl2, 1 mM EDTA) containing 0.2% Triton
X-100 for 2 min at 37°C and then washed and incubated in PEM buffer for 10 min
at 37°C. Free tubulin heterodimers are in this way washed out of the cells,
allowing distinctions between dynamic and stable MT. Cells were then fixed in
PBS–4% PFA and processed for immunofluorescence analysis, as described
above.
Immunoblotting analysis. Western blot (WB) analyses were performed as
previously described (2). In some cases, revelation of signal was performed with
enhanced chemiluminescence (ECL) and in others with Odyssey infrared (IR)
imaging (LI-COR). Primary antibodies were purchased from Sigma (for -tu-
bulin, acetylated -tubulin, Op18/stathmin, and actin), Santa Cruz Biotechnology
(vinculin and RhoA), BD Transduction Laboratories (stathmin/metablastin, p27,
cofilin, and caveolin) Upstate (RhoA), and Cell Signaling (pSer3 cofilin). Sec-
ondary horseradish peroxidase-conjugated antibodies were from Amersham; sec-
ondary IR-conjugated antibodies were from Invitrogen (Alexa Fluor 680) and
from Rockland (IRDye 800).
Wound healing assay. Exponentially growing cells (4  105) were plated in
wells of a six-well plate to create a dense monolayer and then scratched with a
yellow tip. Complete medium was added after washing in PBS, and wound
closure was monitored over the time. After 24 h pictures were taken to calculate
and compare the cellular capacity for closing the scratch.
RhoA activity assay. Exponentially growing MEFs (between passages 3 and 5)
were incubated in serum-reduced medium (0.1% FBS–DMEM) overnight and
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then stimulated with 25 ng/ml basic fibroblast growth factor (bFGF; Calbiochem)
for 5 and 10 min. In other experiments, MEFs were incubated in SFM (0.1%
BSA–DMEM) for 24 h and then detached and kept in suspension in SFM for 30
min at 37°C. Then cells were adhered to FN-coated dishes (25 g/ml; Sigma) for
15 to 30 to 60 min. At the indicated time points, cells were lysed and at least 2
mg of protein was tested in a pulldown assay with glutathione S-transferase
(GST)–mDIA rhotekin binding domain fusion protein bound to glutathione-
Sepharose high performance (GE Healthcare) for 1 h at 4°C, as previously
reported (12). After thorough washes, the samples were boiled for 10 min in
Laemmli buffer to detach active GTP-bound Rho and then loaded on 12.5%
SDS-PAGE gels (Criterion; Bio-Rad) and immunoblotted using an anti-RhoA
antibody.
Lipid raft trafficking. The lipid raft trafficking assay was carried out essentially
as previously described by others (1). Briefly, for the internalization assay, ad-
herent cells were placed on ice for 15 min and then incubated for an additional
15 min with 2 g/ml Alexa Fluor 488- or Alexa Fluor 594-cholera toxin B (CTxB;
Invitrogen) in PBS. Cells were then detached, held in suspension 5 to 60 min,
cytospun, and fixed in PBS–4% PFA for 20 min at RT. For time-lapse analysis,
cells were treated as above but immediately after detachment were dispensed
onto poly-HEMA-coated glass-bottom dishes (Willco wells) to be examined with
a confocal microscope. Images were taken every 30 s for 10 min. When paclitaxel
was used, cells were pretreated for 2 h with 10 or 100 nM paclitaxel and then
labeled and treated as above, always in the presence of paclitaxel. To evaluate
recycling of lipid rafts to the cellular membrane, cells were labeled as above and
then detached and held in suspension for 1 h. Cells were then washed and plated
onto FN-coated coverslips for 30 to 60 min and then fixed in PBS–4% PFA for
20 min at RT. Nuclei were counterstained using 1 M Sytox Green (Invitrogen)
for 20 min at RT. Coverslips were mounted in Mowiol 4-88 (Calbiochem) with
2.5% 1,4-diazabicyclo(2,2,2)octane (Sigma) and observed using a confocal laser-
scanning microscope (TSP2 Leica) interfaced with a Leica DMIRE2 fluores-
cence microscope. Fluorescent signal was quantified using the Leica LAS soft-
ware.
RESULTS
p27 controls cellular morphology through regulation of the
MT network. p27 null 3T3 fibroblasts display an enhanced
motility when challenged in matrix-based migration assays (2).
Concomitantly, we also observed that they displayed a different
morphology from their WT counterpart when immersed in 3D
matrices, since they failed to form long cellular protrusions
and, conversely, assumed an overall rounded shape (Fig. 1A).
This observation was also confirmed on primary MEFs, dem-
onstrating that the different shape acquired in 3D is not due to
clonal selection (see Fig. S1B and C in the supplemental ma-
terial). The immunofluorescence analysis of -tubulin in fibro-
blasts immersed in 3D collagen I showed that the MT network
was differently organized in the presence or absence of p27.
MTs were well distributed throughout the cell body and inside
the protrusions in the WT cells, while they remained located
perinuclearly in the p27 KO cells (Fig. 1B). Under the same
FIG. 1. p27 controls cellular morphology through regulation of the MT network. (A) Phase-contrast microscopy of WT or p27 KO 3T3
fibroblasts immersed in a 3D collagen I matrix for 6 h. A typical image is shown, and a 10 objective was used. (B) Immunofluorescence analysis
of -tubulin (FITC; green) and F-actin (phalloidin; red) in WT or p27 KO MEFs immersed in a 3D collagen I matrix for 6 h. A typical image
acquired by confocal microscopy is shown. (C) Immunofluorescence analysis of acetylated tubulin (green) and F-actin (phalloidin; red) in WT or
p27 KO MEFs immersed in a 3D collagen I matrix for 4 h and subjected to a tubulin dilution assay prior to fixation. A typical image of a 3D
confocal reconstruction is shown. (D) Phase-contrast microscopy of p27 KO MEFs immersed in a 3D collagen I matrix for 6 h (control), in the
presence of 0.5 M cytochalasin D (Cyt. D) or 1 M nocodazole. A typical image is shown, and a 20 objective was used. (E) Immunofluorescence
analysis of -tubulin (FITC; green), F-actin (phalloidin; red), and collagen fibers (reflection; gray) in p27 KO MEFs treated as for panel D. Typical
images of 3D confocal reconstructions (left panels) and of a single confocal section (right panels) of the same fields are shown.
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conditions, the actin cytoskeleton exhibited a peripheral dis-
tribution in both fibroblasts (Fig. 1B). To ascertain whether in
3D MT stability was affected by p27 loss, we performed a
tubulin dilution assay, in which free tubulin dimers are allowed
to flow out of the cell in vivo and only stable MTs are retained,
and this is coupled with immunofluorescence analysis with an
antibody directed against acetylated tubulin, which identifies
the pool of more stable MT in the cell. Results demonstrated
that the different intracellular distribution of MT in p27 KO
cells was accompanied by a significant decrease in the pool of
stable MT (Fig. 1C). To test whether the different morphology
was dependent on a diverse cytoskeletal organization or
whether, on the contrary, the cytoskeletal diversity was only a
consequence of the morphological phenotype, we used low
doses of different drugs that specifically affect the actin or the
tubulin networks. Treatment of WT cells with 0.5 M cytocha-
lasin D (an actin-disrupting drug) did not abrogate the forma-
tion of cellular protrusions, although they appeared to be
shorter than those of control cells (Fig. 1D and E). Conversely,
destabilizing the MT network by using low doses of nocodazole
(1 M) strongly affected the abilities of fibroblasts to assume
their typical mesenchymal shape, as displayed in both phase-
contrast and immunofluorescence images of the cells within
the 3D collagen I matrix (Fig. 1D and E). The results were
confirmed by time-lapse video microscopy, which showed that
WT cells immersed in 3D collagen I started to form protru-
sions within 2 h of inclusion (see Video S1 in the supplemental
material). Cytochalasin D retarded but did not abolish this
process, although it completely inhibited cell movements (see
Video S2). On the contrary, treatment with low doses of
nocodazole prevented protrusion formation and consistently
increased cell motility (see Video S3), closely resembling the
phenotypes of p27 KO cells (see Video S7). These results
suggested that the MT network plays an important role in the
acquisition of proper cellular morphology in 3D matrices and
that this process is altered in p27 KO cells.
We previously demonstrated that p27 participates in the
control of cell motility by interfering with the MT-destabilizing
activity of stathmin (2) and that stathmin activity plays a pivotal
role in the acquisition of a rounded cell shape in 3D environ-
ments (3). To verify that the p27-stathmin interaction is able to
regulate fibroblast cellular morphology in 3D contexts, several
stable cell clones were generated. Results showed that clonal
selection per se (via transfection with an empty vector) did not
alter the morphology or the motility of parental 3T3 p27 WT
and KO fibroblasts (see Fig. S2 in the supplemental material),
and reexpression of p27 WT in p27 null fibroblasts resulted in
a rescue of the morphological and motile phenotypes of p27
null cells (see Fig. S3A, B, and F). In accord with the hypoth-
esis that an unbalanced expression ratio between p27 and
stathmin underlies the observed phenotypes in p27 KO cells,
increasing the stathmin levels in WT fibroblasts resulted in the
acquisition of a rounded cell shape in a 3D context, coupled
with an increased cell speed (see Fig. S3C, D, and E), thus
mimicking key features of p27 null cells. It is noteworthy that
overexpression of stathmin in p27 KO cells did not alter their
3D phenotypes (see Fig. S3 and S5), nor did it affect the
proliferation rate or 2D shape and motility (see Fig. S4) in
either WT or p27 KO fibroblasts.
Altogether, these results demonstrate that the p27/stathmin
expression ratio represents an important determinant for
mouse fibroblast morphology and motility in 3D contexts, and
this is accomplished through the regulation of MT dynamics.
Generation and characterization of p27/stathmin DKO
MEFs. To better address the role of stathmin in the phenotype
of cells lacking p27 expression, we generated p27/stathmin
DKO mice by intercrossing mice heterozygous for both genes.
PCR of embryo genomic DNA and WB analysis on fibroblast
lysates confirmed the correct genotypes of derived MEF pop-
ulations (data not shown, but see Fig. S6A in the supplemental
material). Phase-contrast microscopy images showed that
DKO MEFs displayed a similar morphology to the other ge-
notypes under standard culture conditions (see Fig. S6B, upper
panels). Also, motility in 2D did not differ from that exhibited
by WT and p27 KO MEFs (see Fig. S6C), thus implying that
the cell machinery necessary for 2D migration was not signif-
icantly affected by simultaneous ablation of p27 and stathmin.
Then, we included MEFs from the different genotypes into 3D
matrices either in complete medium (CM) or in SFM and
observed their morphologies at different time points (see Fig.
S6B, middle and lower panels). Alternatively, MEFs were in-
cluded in collagen I drops and monitored over time until they
exited from the drop (see Fig. S6E), or they were tested for
haptotaxis in collagen I-coated transwells (see Fig. S6D). Re-
sults showed that, under all conditions considered, DKO
MEFs behaved in a very similar manner to WT MEFs. They
acquired an elongated shape with multiple extensions protrud-
ing in the 3D matrix, evaded the collagen I drop to a lesser
extent than the fibroblasts with only p27 knocked out, and
migrated comparable to WT cells in collagen I-coated tran-
swells. Thus, the results from the double knockout model in-
directly confirmed that, also in the 3D environment, the mi-
gratory advantage and morphological features of p27 KO cells
are due to increased stathmin activity.
Stathmin loss counteracts the altered MT stability of p27
KO cells. To evaluate whether and how the composition of the
cytoskeletal network of the DKO cells could account for the
rescue of the morphological and migratory phenotypes of p27
KO cells, we performed immunofluorescent staining of the
actin and MT networks in MEFs in a 3D collagen I matrix,
following the tubulin dilution assay. Tubulin staining of DKO
fibroblasts revealed MT localization in the cellular protrusions
and colocalization with the actin cytoskeleton, in a configura-
tion very similar to that of the WT MEFs (Fig. 2A). In partic-
ular, examination of pseudopods and filopodia extending from
the cell body revealed the presence of MT until the very end of
those protrusions in WT and DKO MEFs and attested to the
different arrangements in the p27 KO cells. Again, these latter
fibroblasts appeared much more rounded and their protru-
sions, where present, were shorter and filled only with actin
fibers, reinforcing the idea that MT organization is defective in
these cells. To better characterize the differences in MT sta-
bility in these cells, we stained the cells using an antibody
directed against acetylated tubulin, which marks and identifies
the pool of more stable MTs in the cell. As expected, p27 KO
MEFs displayed a marked decrease of stable MT, while WT
and DKO MEFs exhibited marked staining for stable MT, both
in the cell body and in the protrusions (Fig. 2B). As a comple-
mentary approach, the stability of MT in the MEFs of different
genotypes was evaluated following adhesion to ECM. Adhe-
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sion per se was not affected by loss of p27, stathmin, or both
(see Fig. S7A in the supplemental material), but differential
extraction of soluble and polymerized protein fractions from
cells adhered to fibronectin provided evidence that the de-
crease of stable MT content in p27 KO MEFs was rescued by
DKO MEFs (see Fig. S7B). This result was then confirmed
using 3T3 fibroblasts and another marker of stable MT, dety-
rosinated tubulin (see Fig. S7C). Finally, cells were adhered to
collagen I and then fixed in methanol-acetone to allow the
outflow of soluble tubulin dimers. Immunofluorescence anal-
ysis of acetylated tubulin corroborated the WB results, showing
reduced staining for stable MT in p27 KO MEFs while DKO
and WT fibroblasts displayed similar levels of acetylated MT
(Fig. 2C). Altogether, these results indicate that balanced ex-
pression and activity of p27 and stathmin are required for
correct MT stability, and this, in turn, is necessary for acquiring
the typical mesenchymal morphology and motility of wild-type
fibroblasts in 3D contexts. However, the molecular mechanism
by which these processes are accomplished was still to be
clarified.
The rounded cell shape of p27 KO cells in 3D is associated
with high RhoA activity. The rounded cell morphology and
amoeboid motility in 3D environments have been linked to
hyperactivation of the Rho pathway at the plasma membrane
(38, 39). Interestingly, it has been reported that p27 can affect
cell motility by altering either RhoA (6) or Rac1 (31) activities,
and recent data also demonstrated that adhesion-dependent
activation of small GTPases could be impaired by preventing
MT assembly via high doses of nocodazole (1). Thus, we won-
dered whether the different expression ratios between p27 and
stathmin in MEFs could modify the activation level of the Rho
pathway, and we tested this hypothesis either after growth
factor stimulation or after cell contact with ECM substrates.
After stimulation with FGF, RhoA is more rapidly and
strongly activated in p27 KO MEFs than in the WT counter-
part (Fig. 3A), as previously reported by others (6). Next, we
assayed RhoA activity in MEFs following adhesion to ECM at
very early to late time points. As illustrated in Fig. 3B, p27 KO
MEFs showed increased RhoA activity compared to WT cells
at all considered adhesion times, with a peak of activity after
1 h of adhesion. Conversely, in WT MEFs RhoA activity
reached its peak after 15 min, and then the activity gradually
decreased (Fig. 3B). Importantly, RhoA activity in DKO cells
exactly reproduced the pattern observed in WT MEFs (Fig.
3B). It is noteworthy that the effects observed were specifically
due to pathways activated by cell-ECM contact, because when
RhoA activity was evaluated in cells held in suspension, p27
KO MEFs displayed lower levels of active RhoA than WT or
DKO cells. These results were also confirmed by WB analysis
of phosphorylation levels of pS3 cofilin, a known target of the
RhoA-ROCK1 pathway, following cell adhesion to the ECM
component. The increase of pS3 cofilin levels observed in p27
KO MEFs after 30 and 60 min of cell adhesion was significantly
higher than that in WT cells (Fig. 3C) and was completely
abrogated by treatment of the cells with two specific inhibitors
of the RhoA-ROCK1 pathway (C3 endotoxin and Y27632),
both in p27 KO MEFs (Fig. 3D) and in p27 WT or DKO cells
(data not shown). This confirmed that pS3 cofilin can be used
as a measure of RhoA activation in our model system.
In order to verify whether an alteration of MT stability could
specifically impinge on the Rho pathway, we first treated ex-
ponentially growing WT MEFs with low doses of nocodazole,
aiming to decrease MT stability without completely destroying
the MT cytoskeleton. This resulted in a dose-dependent in-
crease in Ser3 cofilin phosphorylation, reaching a plateau at 0.1
M nocodazole (Fig. 3E, upper panel), suggesting that cross
talk between MT stability and the RhoA pathway existed also
in our context. Then, we tested the same conditions in exper-
iments of adhesion to ECM. In WT cells adhered to FN for 30
and 60 min, nocodazole treatment increased pS3 cofilin levels
in a dose-dependent manner (Fig. 3E, lower panel). Then, as a
reverse approach, p27 KO cells were treated with low doses of
paclitaxel to increase the stability of their MT cytoskeleton.
WB analysis of cells adhered to FN showed a complete abro-
gation of cofilin phosphorylation in the presence of paclitaxes
FIG. 2. DKO MEFs display normal MT organization in a 3D con-
text. (A) Immunofluorescence analysis of -tubulin (FITC; green) and
F-actin (phalloidin, red) in WT, p27 KO, and DKO MEFs immersed in
a 3D collagen I matrix for 6 h and subjected to the tubulin dilution
assay prior to fixation. A typical image acquired by confocal micros-
copy is shown. (B) Immunofluorescence analysis of acetylated tubulin
(green) and F-actin (phalloidin; red) in WT, p27 KO, and DKO MEFs
immersed in a 3D collagen I matrix for 6 h. A typical image acquired
by confocal microscopy is shown. (C) Immunofluorescence analysis of
acetylated tubulin (green) and F-actin (phalloidin; red) in WT, p27
KO, and DKO MEFS alowed to adhere to collagen I for 30 min. Cells
were fixed in methanol-acetone to allow outflow of soluble proteins. A
typical image acquired by confocal microscopy is shown.
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(Fig. 3F). Altogether, these data suggest that p27 influences
adhesion-dependent RhoA activity by regulating MT stability
and that this effect is achieved by its interaction with stathmin,
since it is reversed by simultaneous loss of the two proteins in
the DKO model.
To validate these findings in a 3D environment, we evalu-
ated the phosphorylation of Ser3 cofilin in p27 KO MEFs
included in a 3D collagen I matrix by using immunofluores-
cence analysis. When included in the 3D collagen I, p27 KO
MEFs displayed a significantly higher expression of pS3 cofilin
(Fig. 4A). Computational analysis of the mean level of green
fluorescence/cell demonstrated that the observed differences
were highly statistically significant (mean intensity levels 
standard errors in arbitrary units were as follows: WT, 15  7;
p27 KO, 50  12; DKO, 18  9; P  0.0001 between p27 KO
and WT or DKO; P not significant between WT and DKO
MEFs). Noticeably, treatment of p27 KO cells either with the
C3-exoenzyme or with Y27632 not only resulted in the abro-
gation of cofilin phosphorylation (mean intensity levels 10  4
and 8  5 when the cells were treated with C3 or Y27632,
respectively) but also in the acquisition of an elongated phe-
notype (Fig. 4B; see also Fig. S8A and B in the supplemental
material). Altogether these data strongly support our hypoth-
esis that alteration of RhoA activity is involved in the 3D
morphological phenotype of p27 KO MEFs and that its differ-
ential activation is linked to the altered MT dynamics of these
cells.
Impaired MT stability of p27 KO MEFs results in altered
vesicular trafficking. At this point, we asked the question of
how alterations of proper MT dynamics in our cellular model
system could be responsible for modification of RhoA activity
and, eventually, for morphological and motile transitions. Re-
cently, Schwartz and coworkers demonstrated that MT dynam-
ics control Rac1 activity following cell adhesion to ECM, im-
pinging on lipid raft recycling (1). Lipid rafts represent
membrane microdomains that segregate specific groups of pro-
FIG. 3. Rho A activity is high in p27 KO cells following adhesion to ECM substrates. (A) Results of a pulldown assay of active RhoA in WT
and p27 KO MEFs incubated in reduced serum (0.1%) medium overnight and then stimulated with bFGF (25 ng/ml) for the indicated times.
(B) Results of a pulldown assay of active RhoA in WT, p27 KO, and DKO MEFs. Cells were serum starved for 24 h, detached, and kept in
suspension for 30 min (Sus) and then adhered to FN (30 g/ml) for the indicated times. Data represent the means of three independent
experiments. (C) Western blot analysis of pSer3-cofilin on lysates from WT, p27 KO, and DKO MEFs alowed to adhere to FN (10 g/ml) for the
indicated times. Standard molecular weights are indicated on the right. Vinculin was used as a loading control. (D) Western blot analysis of
pSer3-cofilin on lysates from p27 KO MEFs allowed to adhere to FN (10 g/ml) for the indicated times in the presence of C3-exoenzyme (2 ng/ml)
or Y27632 (10 M). (E) Western blot analysis of pSer3-cofilin on lysates from WT MEFs treated with increasing doses of nocodazole (upper panel)
or cells allowed to adhere to FN (10 g/ml) for the indicated times in the presence of nocodazole at the indicated doses (lower panel). Standard
molecular weights are indicated on the right. (F) Western blot analysis of pSer3-cofilin in lysates from p27 KO MEFs allowed to adhere to FN (10
g/ml) for the indicated times in the presence of 100 nM paclitaxel. Standard molecular weights are indicated on the right.
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teins and exert crucial functions in cellular signaling and pro-
tein trafficking (42). In their report the authors demonstrated
that both the intracellular accumulation of lipid rafts in sus-
pended cells and their relocalization to the plasma membrane
following cell adhesion to ECM require the integrity of MT
(1). These observations are in accord with the notion that MTs
provide a polarized intracellular network that allows organelle
and protein movement throughout the cell, serving as tracks
for intracellular vesicular trafficking that, in turn, are required
for complex cellular functions, such as migration, as well as
division and adhesion. To verify whether an altered intracel-
lular vesicular trafficking could be implicated in the morpho-
logical and motile phenotypes observed in p27 KO cells, we set
up the same assay aimed to monitor internalization of lipid
rafts in these cells. We used the CTxB as a fluorescent marker
for these membrane microdomains (1), both in suspended cells
and following adhesion to ECM. Fibroblasts of different geno-
types were labeled with CTxB while still adherent in the cul-
ture dish, then they were detached and held in suspension for
different times, and finally the cells were cytospun and ob-
served with a confocal microscope. Under these conditions,
CTxB locates at the cell membrane during the labeling proce-
dure and then during suspension starts to be internalized and
moves to a distinct perinuclear region around the MTOC (1).
After 5 min of suspension WT fibroblasts still retain CTxB
labeling at the surface, while in the same time frame many p27
KO cells already exhibit perinuclear accumulation of the toxin
(Fig. 5A). This sharp difference attenuates with time, tending
to disappear after 60 min of suspension (Fig. 5B). If cells are
held in suspension for 60 min and then replated on FN-coated
dishes, CTxB moves again toward the cellular periphery in a
time-dependent manner (1). When performing this kind of
experiment and fixing the cells after 30 min of adhesion to FN,
again we could clearly notice a more rapid redistribution of the
CTxB to the cell membrane in 3T3 p27 KO fibroblasts com-
pared to WT cells. Membrane relocalization of CTxB in DKO
fibroblasts resembled the timing seen in WT cells, suggesting
that the p27/stathmin ratio plays a role also in this process (Fig.
5C and D). Stable reintroduction of p27 in p27 KO cells pro-
duced a cellular response very similar to that of WT cells, thus
confirming that the observed effects were specifically due to the
absence of p27 (Fig. 5A to D). Similarly, the analysis of pri-
mary MEFs showed that the majority of CTxB-labeled lipid
rafts were still spread in the cytoplasm of WT and DKO fibro-
blasts during the first 60 min of adhesion, while they had
already reached the cell membrane in p27 KO cells (Fig. 5E
and F).
These results were then confirmed using video time-lapse
microscopy analysis. For these experiments, cells were prela-
beled with CTxB and observed while in suspension to analyze
the rate of perinuclear accumulation of the rafts. When WT
cells were tested in this type of assay, only a few cells displayed
perinuclear accumulation of CTxB (Fig. 6A, upper panels; see
also Video S4 in the supplemental material), while most of the
p27 KO cells had already internalized the toxin (Fig. 6A, mid-
dle panels; see also Video S5). Importantly, when p27 KO cells
were held in suspension in the presence of 10 or 100 nm
paclitaxes (Fig. 6A and B; see also Video S6), the internaliza-
tion of CTxB was completely prevented, confirming that the
FIG. 4. Rounded cell shapes of p27 KO cells in a 3D matrix is associated with high RhoA activity. (A) Immunofluorescence analysis of
pSer3-cofilin (green) and F-actin (phalloidin; red) in WT, p27 KO, and DKO MEFs immersed in a 3D collagen I matrix for 6 h. A typical image
on the x, y, and z axes acquired by confocal microscopy is shown. (B) Immunofluorescence analysis of pSer3-cofilin (green) and F-actin (phalloidin;
red) (upper panels) or acetylated tubulin (green) and F-actin (phalloidin; red) (lower panels) in p27 KO MEFs immersed in a 3D collagen I matrix
(control) in the presence of C3-exoenzyme (2 ng/ml) or Y27632 (10 M), as indicated. Typical images acquired by confocal microscopy are shown.
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FIG. 5. p27 KO fibroblasts display altered vesicular trafficking. (A) Confocal microscopy of WT, p27 KO, DKO, and p27 KO 3T3 fibroblasts
stably reexpressing p27 and labeled with CTxB (green) to visualize lipid rafts. Cells were labeled for 15 min at 4°C and then detached and kept
in suspension for 5 min to allow the internalization of labeled lipid rafts. White arrowheads indicate cells with perinuclear accumulation of labeled
lipid rafts. Typical images of cytospun cells are shown. (B) Graphical presentation of the results from the experiments shown in panel A, based
on the number cells positive for perinuclear accumulation of labeled lipid rafts at the indicated times of suspension, expressed as a percentage of
total counted cells. The results represent the means of two different experiments, in which at least 100 cells for each cell population and for each
time point were counted. (C) The same experiment as in panel A, except cells were kept in suspension for 60 min to allow complete internalization
of labeled lipid rafts (CTxB; red) and then adhered to FN-coated coverslips for 30 min to monitor lipid raft relocalization to the plasma membrane.
Nuclei were counterstained with Sytox Green (green). (D) Graphical presentation of the ratios between the fluorescence present at the membrane
level and the total fluorescence of the cell, from the experiments described for panel C. The results represent the means of two different
experiments in which at least 20 cells for each cell population and for each time point were analyzed using the Leica LAS software. (E) Same
experiment as in panel C, except that primary MEFs were used. (F) Graphical presentation of the ratios between the fluorescence present at the
membrane level and the total fluorescence of the cell, from experiments described for panel E. The results represent the means of two different
experiments, in which at least 20 cells for each cell population and for each time point were analyzed using the Leica LAS software.
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faster internalization of lipid rafts in the p27 KO cells relied on
the decreased MT stability observed in these cells.
Then, we verified whether this accelerated lipid raft traffick-
ing is a mechanism that also functions during cell-ECM contact
and whether it is linked to the higher RhoA activity measured
in the absence of p27. To this aim, cells were labeled with
CTxB, held in suspension to allow for perinulear accumulation,
and then adhered to FN and fixed for immunofluorescence
analysis. The data showed that, similar to what occurs with
CTxB, increased levels of RhoA protein were localized at the
cell periphery in p27 KO cells respect to WT fibroblasts (Fig.
6C). Again this effect was abrogated by reintroduction of p27
in p27 KO cells (Fig. 6C) and in p27/stathmin DKO MEFs (see
Fig. S8C), confirming that this is a p27-dependent phenotype
due to variation of stathmin activity.
These results suggest that accelerated vesicular trafficking is
linked to increased RhoA activity in p27 KO cells in contact
with ECM, and we hypothesized that this mechanism could
also account for their rounded cell shape and amoeboid-like
motility in 3D contexts.
Thus, we speculated that impinging on vesicular trafficking
of p27 KO cells should affect their shape and motility in 3D.
Recently, it has been proposed that, following cell detachment,
lipid rafts are internalized through caveolae in a process that
requires both dynamin-2 activity and phosphorylation of
caveolin-1 (13). Either a dominant negative dynamin-2 con-
FIG. 6. Altered vesicular trafficking of p27 KO fibroblasts relies on impaired MT stability. (A) Confocal images from time-lapse microscopy
analysis of WT and p27 KO 3T3 fibroblasts. Cells prelabeled with CTxB (green) were detached and layered onto poly-HEMA-coated coverslips
to impede adhesion and observed while in suspension for up to 10 min. In the bottom panels p27 KO 3T3 fibroblasts were pretreated for 2 h with
100 nM paclitaxel and then labeled and treated as described above, always in the presence of paclitaxel. White arrowheads indicate cells with
perinuclear accumulation of labeled lipid rafts. (B) Graphical presentation of the results shown in panel A based on the number of cells positive
for perinuclear accumulation of labeled lipid rafts at the indicated times of suspension, expressed as a percentage of total counted cells. The results
represent the means of three different experiments in which at least 100 cells for each cell population and at each time point were counted.
(C) Immunofluorescence analysis of RhoA (green), F-actin (phalloidin, pseudocolored in blue), and lipid rafts (CTxB; red) in WT p27 KO 3T3
fibroblats and p27 KO 3T3 fibroblasts stably reexpressing p27. Cells were labeled with CTxB, detached, held in suspension for 60 min, allowed to
adhere to FN-coated coverslips for 30 min, and then fixed. In the upper panels RhoA localization is shown in gray. Yellow arrows indicate
membrane localization of CTxB and RhoA. (D) Western blot analysis of caveolin-1 expression in p27 KO 3T3 cells transduced with lentiviral
vectors encoding for nontarget control-specific or two different caveolin-1-specific shRNAs, as indicated. (E) Phase-contrast microscopy images of
p27 KO 3T3 cells stably transduced with two different shRNAs against caveolin 1 (middle and bottom panels) or a nontarget control shRNA (top
panel), included in the 3D collagen I matrix for 5 h. A typical image is shown, and a 20 objective was used. (F) Graphical presentation of IF
analyses for pSer3 cofilin in p27 KO cells transduced or not with nontarget control shRNA or shRNAs against caveolin-1 and included in the 3D
collagen I matrix. Results are expressed as arbitrary units, using Leica LAS software for the computational analysis of mean fluorescent level/cell
and represent the means of three independent experiments in which the fluorescence of at least 20 cells has been calculated.
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struct or knockdown of caveolin 1 completely blocked the
internalization process (13). Similarly, we used two different
approaches to affect the lipid raft trafficking of p27 null cells.
First, we treated cells with Dynasore, a cell-permeant small
molecule that specifically inhibits the GTPase activity of
dynamin (27), in experiments of cell inclusion in 3D collagen I
gels. Video time-lapse microscopy demonstrated p27 KO fi-
broblasts acquire their typical rounded shape coupled with the
amoeboid motility when included in 3D collagen I (see Video
S7 in the supplemental material), but in the presence of Dy-
nasore they formed long protrusions and were no longer able
to move (see Video S8). Second, we knocked down caveolin-1
expression in p27 null cells (Fig. 6D) by using lentiviral trans-
duction of specific shRNAs. Also, caveolin-1 silencing pro-
foundly altered cellular morphology and motility of p27 KO
cells in a 3D context, as demonstrated by phase-contrast ob-
servations and video time-lapse microscopy of cells immersed
in collagen I (Fig. 6E). Caveolin-1-silenced cells were no
longer able to properly move in a 3D collagen I matrix and
started to form long cellular protrusions (Fig. 6E; see also
Videos S9 and S10 in the supplemental material), compared to
p27 KO control cells, thus recapitulating the effects observed
after treatment with Dynasore. Then, to substantiate the idea
that RhoA is the downstream effector of this pathway, we
evaluated the phosphorylation of Ser3 cofilin in p27 KO fibro-
blasts silenced by caveolin. Cells were included in a 3D colla-
gen I matrix, and immunofluorescence analysis was performed
against pSer3 cofilin. Computational analysis of the mean flu-
orescence level/cell demonstrated that caveolin-1-silenced cells
displayed significantly lower staining for pSer3 cofilin than
control p27 KO cells (Fig. 6F), thus supporting the role of lipid
raft recycling in the Rho hyperactivation observed in p27 KO
cells.
DISCUSSION
The coordinated regulation of cell proliferation and migra-
tion and its disorders underlie several physiological and patho-
logical processes, such as embryogenesis, organ development,
and cancer metastasis. In all of these processes p27 and/or
stathmin has been implicated. In an experimental model of
vascular injury in mice, Nabel and coworkers reported that
absence of p27 accelerated wound healing closure (8), while
impairment of stathmin function resulted in an opposite effect
in the same assay (22). Accordingly, in an experimental model
of stroke in mice (18) and in xenograft models of human
tumors (34, 40), overexpression of p27 determined an impaired
neovasculature formation. On the other hand, stathmin abla-
tion in Drosophila melanogaster impairs border cell, germ cell,
and neuronal cell motility (9, 35). Interestingly, while acute
alterations of both stathmin (19) and p27 (20) levels in mice
affect neuronal motility, neither stathmin nor p27 null mice
display apparent anatomical defects in the organization of the
peripheral or central nervous systems (16, 41), suggesting that
compensatory mechanisms must exist to allow for proper
mouse development. However, the molecular characterization
of how p27 and stathmin regulate cell motility was incomplete
to date. Here, we tried to fill this gap by demonstrating that p27
and stathmin act in concert in modulating RhoA activity, via
the modification of MT stability. Other reports have described
how p27 modulates RhoA activity by direct association, but
this has been proven only in overexpression model systems (6).
Interestingly, we recently demonstrated in a v-src transforma-
tion model that absence of p27 is linked to an increase in
RhoA activity, which is then associated with an augmented
metastatic potential (5). This phenotype could be suppressed
by reexpression of p27 protein but only if the domain respon-
sible for the interaction with stathmin were retained (5), thus
supporting our present conclusions. Whether p27-RhoA direct
binding is also present under physiological conditions and
whether it is stathmin dependent will need further work and
could be important to understand.
Cell cycle regulatory proteins already have been implicated
in the control of MT stability, and emerging evidence suggests
that this process, conserved during evolution, represents a cel-
lular expedient to coordinate proliferation and motility. The
most compelling proof comes from yeast, where cyclin-depen-
dent kinase 1 (CDK1) translocates into the cytoplasm after the
completion of mitosis to control MT stability, thus contributing
to guidance of bud formation (25, 28). In higher eukaryotic
model systems, CDK1 and cyclin D1 have been proposed to
take part in the regulation of cell motility (23, 24, 29), at least
in part through the modulation of p27 localization/activity.
Interestingly, cyclin D1 regulation of cell motility also has been
associated with increased expression of stathmin (24), a known
CDK1 substrate (30). Although the regulation of cell motility
by p27 seems to be via a CDK-independent mechanism (2, 5,
6, 31), further work will be necessary to address this point
exhaustively.
The observation that p27 may regulate RhoA activity via
vesicular trafficking describes an unexpected convergence of
distinct lines of evidence. In fact, the roles reported so far for
p27 are pleiotropic and sometimes contrasting: it has been
described as either an inhibitor or stimulator of motility (2, 5,
6, 18, 31) and tumor suppressor or oncogene (4, 7, 15, 16, 33).
Interestingly, stathmin activity also has been linked to vesicular
trafficking regulation in T-helper cells, where it contributes to
the control of interleukin-4 receptor recycling (44), thus inde-
pendently confirming our findings. The data reported by
Tanaka et al. for T cells (44) and by others for neurons (46),
along with our present and previous observations (2, 3), sug-
gest that the activation of stathmin and that of small GTPases
are strongly connected. It is conceivable that, at least during
the first phases of cell-ECM contact, a regulatory loop exists in
order to maintain a balanced activity of these different players,
with increased stathmin activity leading to increased RhoA
activation and increased RhoA activation stabilizing the MT
network after cell adhesion (36). Since RhoA activity also
influences Rac-dependent signaling (reviewed in reference 10),
this could eventually control the stathmin MT-destabilizing
function via phosphorylation of its inhibitory serine residues
(44, 46, 48). In this manner the correct balance between small
GTPase activity and MT stability following cell contact with
ECM could be simply maintained. One link between activation
of RhoA and MT depolymerization has been proposed (11, 21)
following treatment with high doses of nocodazole, resulting in
the activation of RhoA by the release of the RhoA-GEF
GEF-H1 from depolymerized MTs. Yet, the role of GEF-H1
under physiological conditions is still unclear. However, veri-
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fying whether the p27-stathmin interaction regulates the avail-
ability of GEF-H1 is worth considering.
The results of our study demonstrate that fine-tuning of MT
stability can profoundly affect intracellular vesicle recycling
and eventually results in alteration of cell morphology and
motility. Although we did not directly prove that also in 3D
setting p27 KO cells display faster lipid raft trafficking, our data
suggest that their recycling is critical not only for integrin-
mediated signaling pathway modulation in anchorage-depen-
dent cell growth (13) but also for the acquirement of mesenchy-
mal shape and motility in 3D matrices. Since the p27-stathmin
interaction controls cell plasticity and motility in 3D matrices also
in transformed cells (2, 3, 5, 40), possibly via the modulation of
Rho activity (5), the mechanism described here may be relevant
for several aspects of cancer cell behavior, thus highlighting pos-
sible future interventions.
In conclusion, we describe here a totally new p27 function
which eventually controls cellular morphology and motility and
opens new perspectives to the understanding of p27 loss phe-
notypes and its role in tumor progression.
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